The Benchmark Company
http://www.benchmarkcap.com/default.aspThe Benchmark Company, a full-service Broker Dealer, provides financial services to institutional and private clients. Its services include private placements, venture capital, M&A services, recapitalizations, divestitures & spin-offs, equity research as well as other financial services. The firm’s equity research division specializes in the media, energy, enterprise software, infrastructure software, and biotechnology & specialty pharmaceutical sectors.
-
Seelos Therapeutics to Participate in the Benchmark Healthcare Virtual Conference
-
Seelos Therapeutics to Participate in the Benchmark Healthcare Virtual Conference
-
Seelos Therapeutics Announces Closing of Public Offering of Common Stock
-
Seelos Therapeutics Announces Closing of Public Offering of Common Stock
-
Seelos Therapeutics (SEEL) Prices 7.5M Share Common Offering at $0.60/Sh
-
Seelos Therapeutics Announces Pricing of $4.5 Million Public Offering of Common Stock
-
Seelos Therapeutics Announces Pricing of $4.5 Million Public Offering of Common Stock
-
Seelos Therapeutics (SEEL) Announces Proposed Public Offering of Common Stock
-
Seelos Therapeutics Announces Proposed Public Offering of Common Stock
-
Seelos Therapeutics Announces Proposed Public Offering of Common Stock
-
Seelos Therapeutics Announces Closing of Public Offering of Common Stock
-
Seelos Therapeutics Announces Closing of Public Offering of Common Stock
-
Seelos Therapeutics (SEEL) Prices 6.667M Share Common Offering at $0.75/Sh
-
Seelos Therapeutics Announces Pricing of $5 Million Public Offering of Common Stock
-
Seelos Therapeutics Announces Pricing of $5 Million Public Offering of Common Stock
-
Seelos Therapeutics to Participate in Upcoming Investor Conferences in December
-
Seelos Therapeutics to Participate in Upcoming Investor Conferences in December
-
Companies with NDRs 09/26
